JPS58135820A - 放射化モノクロン抗体及びそれを有効成分とする造影剤 - Google Patents
放射化モノクロン抗体及びそれを有効成分とする造影剤Info
- Publication number
- JPS58135820A JPS58135820A JP57188921A JP18892182A JPS58135820A JP S58135820 A JPS58135820 A JP S58135820A JP 57188921 A JP57188921 A JP 57188921A JP 18892182 A JP18892182 A JP 18892182A JP S58135820 A JPS58135820 A JP S58135820A
- Authority
- JP
- Japan
- Prior art keywords
- monoclonal antibody
- tumor
- antibody
- radionuclide
- antibodies
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
- A61K51/1048—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell determinant being a carcino embryonic antigen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
- A61K51/1066—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Optics & Photonics (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Cell Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31528681A | 1981-10-27 | 1981-10-27 | |
US315286 | 1981-10-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS58135820A true JPS58135820A (ja) | 1983-08-12 |
JPH0564130B2 JPH0564130B2 (fr) | 1993-09-14 |
Family
ID=23223718
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP57188921A Granted JPS58135820A (ja) | 1981-10-27 | 1982-10-26 | 放射化モノクロン抗体及びそれを有効成分とする造影剤 |
Country Status (18)
Country | Link |
---|---|
JP (1) | JPS58135820A (fr) |
AT (1) | AT392004B (fr) |
BE (1) | BE894829A (fr) |
CA (1) | CA1202892A (fr) |
CH (1) | CH653040A5 (fr) |
DE (1) | DE3239410A1 (fr) |
DK (1) | DK164682C (fr) |
ES (2) | ES516797A0 (fr) |
FI (1) | FI82379C (fr) |
FR (1) | FR2515046B1 (fr) |
GB (1) | GB2109407B (fr) |
IL (1) | IL67068A0 (fr) |
IT (1) | IT1153857B (fr) |
LU (1) | LU84441A1 (fr) |
NL (1) | NL8204108A (fr) |
NO (1) | NO169947C (fr) |
SE (1) | SE8206073L (fr) |
ZA (1) | ZA827806B (fr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60214261A (ja) * | 1984-04-10 | 1985-10-26 | Takeda Chem Ind Ltd | ヒト癌胎児性抗原反応性モノクローナル抗体の製造法 |
JP2008195715A (ja) * | 1995-05-16 | 2008-08-28 | Purdue Res Found | 腫瘍画像化法および組成物 |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4957939A (en) * | 1981-07-24 | 1990-09-18 | Schering Aktiengesellschaft | Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging |
CA1225930A (fr) * | 1982-06-07 | 1987-08-25 | Otto A. Gansow | Anticorps monoclonaux conjugues avec des chelates metalliques |
US4741900A (en) * | 1982-11-16 | 1988-05-03 | Cytogen Corporation | Antibody-metal ion complexes |
GB2140030A (en) * | 1983-04-08 | 1984-11-21 | Kureha Chemical Ind Co Ltd | Monoclonal antibody to human urinary bladder cancer |
GB2139645A (en) * | 1983-04-08 | 1984-11-14 | Kureha Chemical Ind Co Ltd | Antibody to human prostrate cancer |
JPS59199636A (ja) * | 1983-04-26 | 1984-11-12 | Nippon Mejifuijitsukusu Kk | 放射性診断剤 |
US4677058A (en) * | 1983-05-19 | 1987-06-30 | Karl Tryggvason | Detecting malignant cells with monoclonal antibodies specific to type IV collagenase enzyme |
US4732864A (en) * | 1983-10-06 | 1988-03-22 | E. I. Du Pont De Nemours And Company | Trace-labeled conjugates of metallothionein and target-seeking biologically active molecules |
JPS60201260A (ja) * | 1984-03-27 | 1985-10-11 | Yamasa Shoyu Co Ltd | 心疾患診断薬 |
US4898724A (en) * | 1984-06-04 | 1990-02-06 | The Dow Chemical Company | Organis amine phosphonic acid complexes for the treatment of calcific tumors |
CA1260827A (fr) * | 1984-08-31 | 1989-09-26 | Richard C. Siegel | Complexes anticorps - ions metalliques |
US4837003A (en) * | 1984-09-13 | 1989-06-06 | Mallinckrodt, Inc. | Radiolabeled antibody fragments |
US4659839A (en) * | 1984-10-10 | 1987-04-21 | Mallinckrodt, Inc. | Coupling agents for radiolabeled antibody fragments |
US5242679A (en) * | 1985-01-14 | 1993-09-07 | Neorx Corporation | Metal radionuclide labeled proteins for diagnosis and therapy |
US4897255A (en) * | 1985-01-14 | 1990-01-30 | Neorx Corporation | Metal radionuclide labeled proteins for diagnosis and therapy |
US4986256A (en) * | 1985-02-28 | 1991-01-22 | The United States Of America As Represented By The Department Of Health And Human Services | Use of paramagnetic metalloporphyrins as contrast agents for tumors in MRI imaging |
US4824986A (en) * | 1985-04-26 | 1989-04-25 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Metal chelate protein conjugate |
US4830847A (en) * | 1985-06-28 | 1989-05-16 | The Procter & Gamble Company | Diphosphonate-derivatized macromolecules |
US4732974A (en) * | 1986-03-05 | 1988-03-22 | Mallinckrodt, Inc. | Metal ion labeling of carrier molecules |
US4877868A (en) * | 1986-03-12 | 1989-10-31 | Neorx Corporation | Radionuclide antibody coupling |
US4861869A (en) * | 1986-05-29 | 1989-08-29 | Mallinckrodt, Inc. | Coupling agents for joining radionuclide metal ions with biologically useful proteins |
US5082930A (en) * | 1986-05-29 | 1992-01-21 | Mallinckrodt Medical, Inc. | Coupling agents for joining radionuclide metal ions with biologically useful proteins |
US4925804A (en) * | 1986-06-17 | 1990-05-15 | Baxter International Inc. | Interligand metal transfer assay |
US5246692A (en) * | 1986-09-05 | 1993-09-21 | The United States Of America As Represented By The Secretary Of Health And Human Services | Backbone polysubstituted chelates for forming a metal chelate-protein conjugate |
US4831175A (en) * | 1986-09-05 | 1989-05-16 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Backbone polysubstituted chelates for forming a metal chelate-protein conjugate |
FR2604092B1 (fr) * | 1986-09-19 | 1990-04-13 | Immunotech Sa | Immunoreactifs destines a cibler les cellules animales pour leur visualisation ou leur destruction in vivo |
CA1340014C (fr) * | 1986-10-27 | 1998-08-25 | Bryan Michael Longenecker | Anticorps monoclonaux marqueurs de carcinomes; leur elicitation avec l'antigene asialo-gmi |
US5227474A (en) * | 1987-02-13 | 1993-07-13 | Abbott Laboratories | Bifunctional chelating agents |
US5057302A (en) * | 1987-02-13 | 1991-10-15 | Abbott Laboratories | Bifunctional chelating agents |
DE3710730A1 (de) * | 1987-03-31 | 1988-10-20 | Schering Ag | Substituierte komplexbildner, komplexe und komplexsalze, verfahren zu deren herstellung und diese enthaltende pharmazeutische mittel |
US5053493A (en) * | 1987-04-02 | 1991-10-01 | Centocor Cardiovascular Imaging Partners, L.P. | Method for labeling antibodies with a metal ion |
US5177192A (en) * | 1987-04-02 | 1993-01-05 | Centocor, Incorporated | Method for labeling antibodies with a metal ion |
US4838274A (en) * | 1987-09-18 | 1989-06-13 | Air Products And Chemicals, Inc. | Perfluoro-crown ethers in fluorine magnetic resonance imaging |
US5217704A (en) * | 1987-11-06 | 1993-06-08 | Abbott Laboratories | Methods and materials for the preparation of metal labelled antibody solutions |
US5648471A (en) * | 1987-12-03 | 1997-07-15 | Centocor, Inc. | One vial method for labeling antibodies with Technetium-99m |
US4867962A (en) * | 1988-02-26 | 1989-09-19 | Neorx Corporation | Functionally specific antibodies |
US5075099A (en) * | 1988-05-31 | 1991-12-24 | Neorx Corporation | Metal radionuclide chelating compounds for improved chelation kinetics |
US4988496A (en) * | 1988-05-31 | 1991-01-29 | Neorx Corporation | Metal radionuclide chelating compounds for improved chelation kinetics |
US5218128A (en) * | 1988-06-15 | 1993-06-08 | Centocor, Inc. | Bifunctional coupling agents and radionuclide labeled compositions prepared therefrom |
US5792444A (en) * | 1989-05-09 | 1998-08-11 | The General Hospital Corporation | Labeled chemotactic peptides to image focal sites of infection or inflammation |
US5807535A (en) * | 1992-07-31 | 1998-09-15 | Australian Nuclear Science & Technology Organisation | Metal complexes of hydroxyaryl containing aminocarboxylic acid chelating agents |
US5550160A (en) * | 1992-07-31 | 1996-08-27 | Australian Nuclear Science & Technology Organization | Metal complexes of hydroxyaryl containing aminocarboxylic acid chelating agents |
US6558669B1 (en) | 1996-08-28 | 2003-05-06 | Immunomedics, Inc. | Stable radioiodine conjugates and methods for their synthesis |
US7521531B2 (en) | 1996-08-28 | 2009-04-21 | Immunomedics, Inc. | Methods for the purification of stable radioiodine conjugates |
US6663866B1 (en) | 1996-08-28 | 2003-12-16 | Immunomedics, Inc. | Stable radioiodine conjugates and methods for their synthesis |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5695119A (en) * | 1979-10-29 | 1981-08-01 | University Patents Inc | Method and composition for detecting human cancer |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4323546A (en) * | 1978-05-22 | 1982-04-06 | Nuc Med Inc. | Method and composition for cancer detection in humans |
US4272503A (en) * | 1978-05-25 | 1981-06-09 | New England Nuclear Corporation | Reductant composition for technetium-99m and method for making technetium-99m labelled ligands |
JPH036125B2 (fr) * | 1980-03-03 | 1991-01-29 | Miruton Deebitsudo Goorudenbaagu |
-
1982
- 1982-10-25 NL NL8204108A patent/NL8204108A/nl not_active Application Discontinuation
- 1982-10-25 NO NO823530A patent/NO169947C/no unknown
- 1982-10-25 AT AT0391682A patent/AT392004B/de not_active IP Right Cessation
- 1982-10-25 ES ES516797A patent/ES516797A0/es active Granted
- 1982-10-25 FI FI823633A patent/FI82379C/fi not_active IP Right Cessation
- 1982-10-25 FR FR8217800A patent/FR2515046B1/fr not_active Expired
- 1982-10-25 GB GB08230356A patent/GB2109407B/en not_active Expired
- 1982-10-25 DE DE19823239410 patent/DE3239410A1/de active Granted
- 1982-10-26 SE SE8206073A patent/SE8206073L/ not_active Application Discontinuation
- 1982-10-26 IT IT23932/82A patent/IT1153857B/it active
- 1982-10-26 ZA ZA827806A patent/ZA827806B/xx unknown
- 1982-10-26 CH CH6239/82A patent/CH653040A5/de not_active IP Right Cessation
- 1982-10-26 DK DK474182A patent/DK164682C/da active
- 1982-10-26 LU LU84441A patent/LU84441A1/fr unknown
- 1982-10-26 CA CA000414208A patent/CA1202892A/fr not_active Expired
- 1982-10-26 IL IL67068A patent/IL67068A0/xx not_active IP Right Cessation
- 1982-10-26 JP JP57188921A patent/JPS58135820A/ja active Granted
- 1982-10-27 BE BE0/209345A patent/BE894829A/fr not_active IP Right Cessation
-
1984
- 1984-01-31 ES ES529310A patent/ES529310A0/es active Granted
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5695119A (en) * | 1979-10-29 | 1981-08-01 | University Patents Inc | Method and composition for detecting human cancer |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60214261A (ja) * | 1984-04-10 | 1985-10-26 | Takeda Chem Ind Ltd | ヒト癌胎児性抗原反応性モノクローナル抗体の製造法 |
JP2008195715A (ja) * | 1995-05-16 | 2008-08-28 | Purdue Res Found | 腫瘍画像化法および組成物 |
Also Published As
Publication number | Publication date |
---|---|
FR2515046B1 (fr) | 1985-11-29 |
AT392004B (de) | 1991-01-10 |
DK164682B (da) | 1992-08-03 |
IT1153857B (it) | 1987-01-21 |
NL8204108A (nl) | 1983-05-16 |
CH653040A5 (de) | 1985-12-13 |
NO169947C (no) | 1992-08-26 |
ATA391682A (de) | 1990-07-15 |
NO823530L (no) | 1983-04-28 |
JPH0564130B2 (fr) | 1993-09-14 |
FI823633A0 (fi) | 1982-10-25 |
ES8505482A1 (es) | 1985-05-16 |
DK164682C (da) | 1992-12-21 |
FI82379C (fi) | 1991-03-11 |
GB2109407B (en) | 1985-12-18 |
IT8223932A0 (it) | 1982-10-26 |
ES8404857A1 (es) | 1984-05-16 |
FR2515046A1 (fr) | 1983-04-29 |
CA1202892A (fr) | 1986-04-08 |
FI82379B (fi) | 1990-11-30 |
GB2109407A (en) | 1983-06-02 |
BE894829A (fr) | 1983-02-14 |
IL67068A0 (en) | 1983-02-23 |
DE3239410C2 (fr) | 1991-12-19 |
NO169947B (no) | 1992-05-18 |
DE3239410A1 (de) | 1983-05-19 |
ES516797A0 (es) | 1984-05-16 |
DK474182A (da) | 1983-04-28 |
SE8206073L (sv) | 1983-04-28 |
ES529310A0 (es) | 1985-05-16 |
SE8206073D0 (sv) | 1982-10-26 |
FI823633L (fi) | 1983-04-28 |
ZA827806B (en) | 1983-08-31 |
LU84441A1 (fr) | 1983-06-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS58135820A (ja) | 放射化モノクロン抗体及びそれを有効成分とする造影剤 | |
Garg et al. | Comparative tissue distribution in mice of the α-emitter 211At and 131I as labels of a monoclonal antibody and F (ab′) 2 fragment | |
Meijs et al. | Zirconium-labeled monoclonal antibodies and their distribution in tumor-bearing nude mice | |
CA2789433C (fr) | Complexes emettant des particules alpha ciblees comportant un radionucleide du thorium 227 et un hydroxyyridinone renfermant un ligand | |
Zalutsky et al. | Radiohalogenation of a monoclonal antibody using an N-succinimidyl 3-(tri-n-butylstannyl) benzoate intermediate | |
Schott et al. | Differential metabolic patterns of iodinated versus radiometal chelated anticarcinoma single-chain Fv molecules | |
DE3650172T2 (de) | Diphosphonatderivierte Makromoleküle. | |
JPH06501703A (ja) | 治療用及び診断用撮像組成物及び方法において役立つ錯化剤及びターゲティング放射性免疫試薬 | |
WO1991014459A1 (fr) | Ligand du type dtpa bifonctionnel | |
Milenic et al. | In vivo evaluation of bismuth-labeled monoclonal antibody comparing DTPA-derived bifunctional chelates | |
Zimmermann et al. | Targeting of renal carcinoma with 67/64Cu-labeled anti-L1-CAM antibody chCE7: selection of copper ligands and PET imaging | |
Goodwin et al. | Biological properties of biotin-chelate conjugates for pretargeted diagnosis and therapy with the avidin/biotin system | |
Wilbur | [211At] astatine-labeled compound stability: issues with released [211At] astatide and development of labeling reagents to increase stability | |
US5310536A (en) | Ligands for improving metal chelate formation kinetics | |
Junghans et al. | Pharmacokinetics and Bioactivity of 1, 4, 7, 10-tetra-azacylododecane N, N′, N ″, N‴-tetraacetic acid (DOTA)-Bismuth-conjugated Anti-Tac Antibody for α-Emitter (212Bi) Therapy | |
JP2012131808A (ja) | 減少した正味の正電荷を有する抗体 | |
Hens et al. | Labeling internalizing anti-epidermal growth factor receptor variant III monoclonal antibody with 177Lu: in vitro comparison of acyclic and macrocyclic ligands | |
Yordanov et al. | Antitenascin antibody 81C6 armed with 177Lu: in vivo comparison of macrocyclic and acyclic ligands | |
Stein et al. | Advantage of a residualizing iodine radiolabel for radioimmunotherapy of xenografts of human non-small-cell carcinoma of the lung | |
Alirezapour et al. | Optimized preparation and preliminary evaluation of [64 Cu]–DOTA–trastuzumab for targeting ErbB2/Neu expression | |
Quadri et al. | Evaluation of indium-111-and yttrium-90-labeled linker-immunoconjugates in nude mice and dogs | |
Alauddin et al. | An improved method of direct labeling monoclonal antibodies with 99mTc | |
Buchsbaum et al. | Comparison of the distribution and binding of monoclonal antibodies labeled with 131-iodine or 111-indium | |
EP0630264A4 (fr) | Ligands permettant d'ameliorer la cinetique de formation d'agents chelateurs. | |
Rea et al. | Site-specifically radioiodinated antibody for targeting tumors |